Study Stakes San Diego’s Claim in Genomics: $292M in 2016 VC Deals

Xconomy

Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp.

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list.

Trending Sources

San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals

Xconomy

Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. million in 49 startups in San Diego County during the third quarter, according to a breakout of data provided by PitchBook as part of the inaugural “Venture Monitor” report. San Diego. $35 San Diego. $20

Santa Barbara, San Diego Tops On Per-Capita Venture Capital

socalTECH

A new study released earlier this month has ranked the Santa Barbara-Santa Maria-Goleta metropolitan area, as well as the San Diego-Carlsbad-San Marcos metropolitan area among the top ten markets for venture capital activity. San Jose-Sunnyvale-Santa Clara; 2.

San Diego, Irvine Tops For Engineering Job Demand, Says Report

socalTECH

Two, Southern California markets-- San Diego and Irvine --are among the top ares for engineering job demand, according to a report today. listings monster technology engineering employment jobs irvine diego

Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio

Xconomy

It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference. There has been plenty of talk since about closing biotech’s notable gender gap. At this year’s J.P

Report: Biotech VCs Perpetuate Boardroom Gender Gap

Xconomy

If power in the business world is centered in the boardroom, women in biotech have a long way to go to get their fair share—and the venture community deserves much of the blame.

Study 32

Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More

Xconomy

The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python this week; after extending its maw around the supersized meal of news and data from the American Society for Clinical Oncology meeting over the weekend, life science info flow nearly came to a halt. James Comey might have had a wee bit to do with that, as well.)

News 20

ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity

Xconomy

[ Note: Ben Fidler coauthored this report.] The American Society of Clinical Oncology conference is wrapping up, and the closely-watched medical meeting-slash-hype machine produced its usual array of data.

Two San Diego Sites Rank Tops In Rising Social Networking Interest

socalTECH

A report issued this week by Experian Marketing Services has identified two, San Diego niche social networking sites as being among the fastest growing sites between July of 2011 and July of 2012.

Gottlieb Reportedly On Tap to Lead FDA, and Biopharma Exhales

Xconomy

According to several news reports, the Trump administration will nominate Scott Gottlieb to be the new commissioner of the FDA, a selection that had the life sciences industry breathing a sigh of relief Friday afternoon.

News 34

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent

Xconomy

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center commissioned the report to help quantify the economic impact of the cybersecurity industry in San Diego, and to assess how employers view their prospects for growth and needs for future hiring.

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures.

Study 37

Synthetic Genomics Creates Host Organism Optimized for Bio Industry

Xconomy

Scientists from Synthetic Genomics, the San Diego-based industrial biotech, have re-engineered a fast-growing microorganism found in salt marsh mud to maximize its production of proteins and to optimize other common bio-based processes.

Sony Slashes Staff At San Diego Game Studio

socalTECH

Sony has cut more than 50 employees in San Diego, at its Sony San Diego Studio , which develops videogames such as Kill Strain and MLB. According to reports , the layoffs are part of a wider cut in its videogaming operations which also included workers in London. Gamasutra reported the moves are possibly a move away from "live games" development at Sony. sony diego studios videogame studio layoff jobs employment online games

Dauntless Takes Flight with New Business Model for Starting Biotechs

Xconomy

First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. David Kabakoff, a Sofinnova partner in San Diego, also is a Dauntless board member.

At “The Vine,” Developer Builds a Vertical Campus for Tech Startups

Xconomy

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego.

VC Confidence Holds Steady in Quarterly Survey, But Reasons Change

Xconomy

That Q4 2016 edition of a quarterly survey by University of San Francisco business professor Mark Cannice rated the overall confidence of the VCs at 3.81

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches

Xconomy

“A number of patients are sick and tired of chemo, so they’ll roll the dice, knowing they won’t stay on the study” if they are assigned to take chemo, says Andrew Ko, a gastrointestinal cancer specialist at the University of California, San Francisco.

Study 36

Raken Gets $2M For Construction Reporting Software

socalTECH

San Diego-based Raken has raised $2M in a funding round, for the company's construction reporting and compliance software. raken venture capital construction reporting softwareThe funding was led by Rincon Venture Partners , and also included Eniac Ventures and Spider Capital. Raken is led and was co-founded by CEO Kyle Slager and CTO/CPO Dr. Sergey Sundukovskiy.

CTO 44

Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?

Xconomy

A 2014 report provided a stark frame of reference for the challenge of fighting Alzheimer’s disease, showing that 99.6 Led by Jeffrey Cummings, director of the Cleveland Clinic’s Lou Ruvo Center for Brain Health, the same authors recently published a new report on the Alzheimer’s drug pipeline. percent of all drugs in the field had failed in one way or another.

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning

Xconomy

On the day after Intel announced its acquisition of San Diego machine learning startup Nervana Systems, investor Steve Jurvetson told me he was feeling a sense of satisfaction about a call he made three years ago, and how it has been playing out.

ViaCyte Working with Gore to Improve its Synthetic Pancreas Device

Xconomy

San Diego-based ViaCyte said today it is collaborating with W.L. When ViaCyte reported preliminary results from its initial clinical.

Websense, After Move From San Diego, In Acquisition Talks

socalTECH

Former San Diego-based security software developer Websense > --one of a number of companies acquired by private equity investor Vista Equity Partners and moved out of San Diego--is now in talks to be acquired by Raytheon , according to a report. Bloomberg reports that the companies are in talks to sell Websense to Raytheon in a deal worth more than $1 billion.

Raken Expands In San Diego

socalTECH

San Diego-based construction compliance and reporting software developer Raken announced this morning that it is expanding its footprint in San Diego, and has moved into a new space at make (cq) in Carlsbad. raken diego construction compliance reporting software growth expansion headquarters

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

Xconomy

Watson Health is teaming up with 16 partners, which include imaging and diagnostics company Hologic; Sentara Healthcare; Sheridan Healthcare; UC San Diego Health; University of Miami Health System; and Merge Healthcare, which was acquired by IBM last year and is now part of Watson Health.

IBM 37

New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies

Xconomy

Christensen made his observations during a presentation at the 2016 Contextual Robotics Forum, a recent conference at UC San Diego focused this year on “new directions in human-machine interaction.”.

Texas Looks To Steal Away Another San Diego Company, Omnitracs

socalTECH

According to reports, Omnitracs is in the midst of negotations to move its operations out of San Diego, and to Austin, following the recent sale of Omnitracs by Qualcomm to private equity firm Vista Equity Partners. If the deal goes through, the company will be the second Vista Equity owned company in San Diego to move to Austin, after the move last week of computer security software WebSense --also owned by Vista Equity. texas diego omnitracs jobs employment

14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)

Xconomy

Editor’s note: Ben Fidler and Frank Vinluan contributed to this report.] We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here , with looks at key studies in lung cancer, Alzheimer’s disease, asthma, and more.

San Diego's Mapp Bio Behind Experimental Ebola Drug

socalTECH

A San Diego-based biopharmaceuticals startup, Mapp Biopharmaceuticals , is the source of the experimental Ebola treatment that has been given to the two Americans who are being treated for the dreaded disease, according to CNN. According to the report, Dr. Kent Brantly and Nancy Writebol, who were both in Liberia, have both been treated using the experimental, treatment, which had not yet been tested in humans, and have "significantly improved" due to the drug.

BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders

Xconomy

As Xconomy reported last year, South San Francisco, CA-based BlackThorn was spun out of Scripps Research Institute , which on its website lists the company as one of its 2013 spinouts.

Study 29

All In One Place: A New Immuno-Oncology Trial Resource

Xconomy

As reporters, we find that frustrating. More than 100 years ago, New York bone surgeon William Coley began to suspect that bacterial infections might be improving the outlook for patients also suffering from cancer. The infections were turbo-charging the immune system.

New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease

Xconomy

In August, Biogen and Ionis reported positive data from a trial in infants with type 1 SMA and, as with its news today, stopped that study so that patients could transition to an open-label extension study and get nusinersen.

Study 28